Merrion Pharmaceuticals announces liquidation plan
Company could have around €4.5m to distribute to shareholders
The board of Dublin-listed Merrion Pharmaceuticals has proposed that the company be wound up, with its remaining funds distributed to shareholders.
Followingthe sale of its intellectual property assets to drug giant Novo Nordisk and changes to the licence agreements between the two companies last year, Merrion became an investment company with a focus on the healthcare sector.
In a statement today, however, Merrion said its board had looked at a number of investment ...
